The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member
| Task Force Number | Task Force Name | Task Force Chairs |
|---|---|---|
| TF-2025-15 | European Respiratory Society Short Guideline on Anti-inflammatory treatment for adults with bronchiectasis | Melissa McDonnell, Stefano Aliberti |
| TF-2025-13 | ERS Guidelines for the treatment of pulmonary arterial hypertension | Gabor Kovacs, Marion Delcroix, Katarina Zeder |
| TF-2025-10 | Clinical practical guidelines on diagnostic of Immune-Related Interstitial Lung Disease (IR-ILD) | Julien Guiot, Joanna Porter, Laura Fabbri |
| TF-2025-08 | ERS Statement on Defining the Disease Classification and Nomenclature of Chronic Cough in Adults | Woo-Jung Song, Alyn Morice, Ana Oliveira |
| TF-2025-07 | Core Outcome Set for Clinical Trials on Chronic Obstructive Pulmonary Disease maintenance pharmacotherapy | Alexander Mathioudakis, Lies Lahousse, Sachin Ananth |
| TF-2025-04 | ERS Statement on Pleural Tuberculosis | Jane Shaw, Eihab Bedawi, Radhika Banka |
| TF-2025-01 | CPG on the management of children and adolescents with protracted bacterial bronchitis and chronic wet/productive cough unrelated to bronchiectasis | Anne Chang Ahmad Kantar, Julie Marchant |
| TF-2024-28 | An official ERS statement on work related asthma | Sara De Matteis, Rafael de la Hoz, Orianne Dumas |
| TF-2024-27 | Management of Severe Asthma: A European Respiratory Society/American Thoracic Society Guideline | Andrew Bush, Fernando Holguin |
| TF-2024-24 | ERS Clinical Practice Guideline on optimal diagnostic imaging in children with congenital lung malformations (CLM) | Marco Schnater, Sune Rubak, Louis Dossche |
| TF-2024-22 | ERS Clinical Practice Guideline for the Pharmacological Maintenance Treatment of COPD | Daiana Stolz, Mona Bafadhel, Andreas Hoheisel |
| TF-2024-21 | ERS Statement on physical activity in adults with respiratory disease – the 2026 update | Heleen Demeyer, Henrik Watz, Mark Orme |
| TF-2024-19 | ERS Statement: Defining and Detecting Drug-Associated Pulmonary Arterial Hypertension | David Montani, Laura Price, Léon Genecand |
| TF-2024-18 | ERS Statement on Pregnancy and Reproductive Health in Respiratory Disease | Karen Olsson, Monika Gappa, Sara Cuevas Ocaña |
| TF-2024-17 | ERS Statement on Childhood interstitial lung diseases (chILD): definition, characterization, and long term disease behaviour into adulthood | Matthias Griese, Effrosyne Manali, Vaclav Koucky |
| TF-2024-15 | ERS Statement on Transitioning Adolescents and Young Adults (AYA) with Bronchiectasis. | Laura Garriga-Grimau, Stefano Aliberti |
| TF-2024-10 | Clinical Practice Guideline on treatment of lung disease in alpha-1antitrypsin | Alice Turner, Marc Miravitlles, Miram Barrecheguren Fernandez |
| TF-2024-09 | Statement on imaging in the diagnosis and follow-up of complicated paediatric pneumonia | Alexander Moeller, Jovan Lovrenski |
| TF-2024-07 | ERS Statement on Interprofessional Education in Pulmonary Rehabilitation | Ana Oliveira, Guido Vagheggini |
| TF-2024-06 | Evidence-based minimum standard guideline for chronic pulmonary aspergillosis and guidance for excellent care | Eva Van Braeckel, David Denning |
| TF-2024-05 | Clinical Practice Guideline on Airway Clearance Management for Children and Adolescents with Non-Cystic Fibrosis Chronic Suppurative Lung Diseases, and hospitalised Pneumonia and Bronchiolitis | Pamela Laird, Ahmad Kantar |
| TF-2024-01 | Unpaid/Family caregiving for adults with chronic respiratory disease | Alda Marques, Daisy Janssen |
| TF-2023-17 | Statement on management of solitary fibrous tumors of the pleura | Najib M. Rahman, Giuseppe Cardillo, Mohammed El-Layeh, Rachel Mercer |
| TF-2023-16 | ERS Statement on limb and respiratory muscle dysfunction in COPD | Daniel Langer, Harry Rossiter, Andre Nyberg, Amy Attaway |
| TF-2023-14 | ERS Statement on moderate to severe asthma remission | Salman Siddiqui, Celeste Porsbjerg, Nizar Jarjour, Stefania Principe |
| TF-2023-10 | Diagnosis and management of Pulmonary Hypertension associated with Interstitial Lung Diseases | Steven Nathan, Vincent Cottin, Laura Price, Sandeep Sahay |
| TF-2023-09 | ATS/ERS Clinical Practice Guideline on Physical Rehabilitation and Mobilization for Critically Ill Adult Patients | Rik Gosselink, Carol Hodgson, Sabrina Eggmann, Jain Snigdha |
| TF-2023-05 | ERS Statement on redefining pulmonary arterial hypertension with cardiopulmonary comorbidities | Harm Jan Bogaard, George Giannakoulas |
| TF-2023-04 | ERS Statement on ultrasound guided interventions performed by respiratory physicians and thoracic surgeons | Christian B. Laursen, Najib M.Rahman, Maged Hassan |
| TF-2023-03 | ERS Clinical Practice Guidelines on combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer | Jouke Annema, Peter Vilmann, Daniel Korevaar |
| TF-2023-02 | ERS Statement on management of cardiac comorbidities in hospitalized patients with an exacerbation of COPD | Frits Franssen, Peter Alter |
| TF-2023-01 | ERS Statement on Paediatric Neurodisability and Respiratory Morbidity | Sarah Brown, Dirk Schramm |
| TF-2022-19 | ERS/ATS Clinical Practice Guideline for the diagnosis of Primary Ciliary Dyskinesia | Amelia Shoemark, Amjad Horani |
| TF-2022-16 | Clinical Practice Guideline on the management of patients with Idiopathic pulmonary fibrosis (IPF) and Lung Cancer | Michael Kreuter, Argyris Tzouvelekis |
| TF-2022-10 | Clinical Practice Guidelines on management of positive findings from low-dose CT screening for lung cancer | Torsten Gerriet Blum, Marie-Pierre Revel |
| TF-2022-09 | ERS Research Statement on diagnosis and management of post-COVID interstitial lung disease | Claudia Ravaglia, Maria Molina-Molina |
| TF-2022-08 | ERS Clinical Practice Guidelines on the Management of Adult Bronchiectasis | James D. Chalmers, Stefano Aliberti |
| TF-2022-07 | ERS Technical Standards for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension | Philippe Brénot, Hiromi Matsubara |
| TF-2022-01 | ERS Clinical Practice Guidelines on continuous positive airway pressure (CPAP) for the treatment of adult obstructive sleep apnoea (OSA) | Dries Testelmans, Winfried Randerath, Esther Irene Schwarz |
| TF-2021-18 | Update of the International Multidisciplinary Classification of the Interstitial Pneumonias | Andrew Nicholson, Chris Ryerson |
| TF-2021-10 | Core outcome set for trials evaluating the management of pneumonia – an ERS Statement | Timothy Felton, Tobias Welte |
| TF-2021-09 | Developing Global Lung Function Initiative (GLI) reference equations for cardiopulmonary exercise testing (CPET) – an ERS Technical Standard | Karl Sylvester, Helge Hebestreit |
| TF-2021-05 | ERS Statement on Advanced Telemedicine for Sleep Disordered Breathing | Maria Bonsignore, Johan Verbraecken |
| TF-2020-07 | ERS/ESTS Clinical Practice Guideline Task Force on fitness for tumour-specific treatments of lung cancer | Alessandro Brunelli, Huber Rodolfo Maria, Georgia Hardavella |
| TF-2020-06 | ERS Statement on dyspnoea: a multidimensional and multidisciplinary approach | Pierantonio Laveneziana, Louis Laviolette |
| TF-2020-03 | ERS/EULAR Clinical practice guideline on connective tissue diseases with interstitial lung (ILD) involvement | Katerina Antoniou, Bruno Crestani, Anna-Maria Hoffmann-Vold, Oliver Distler |
| TF-2018-08 | Statement on diagnosis and investigation of central sleep apnoea in children aged 1 month to 18 years | Hui-Leng Tan |